Myelosuppression is a condition where your bone marrow stops producing enough blood cells. Your bone marrow, the soft spongy tissue inside your bones, normally generates and releases billions of red blood cells, white blood cells, and platelets every day. When something disrupts that process, levels of one or more of these cell types drop, leaving you vulnerable to anemia, infections, and uncontrolled bleeding.
How Bone Marrow Production Breaks Down
Inside your bones, specialized stem cells called hematopoietic progenitor cells continuously divide and mature into the three main types of blood cells. Red blood cells carry oxygen. White blood cells fight infection. Platelets help your blood clot. Myelosuppression occurs when something damages or overwhelms these stem cells so they can’t keep up with the body’s demand for new blood cells.
The suppression can affect all three cell lines at once or hit one harder than the others. When white blood cells drop, the condition is called neutropenia. A drop in red blood cells is anemia. Low platelets are called thrombocytopenia. Many people with myelosuppression experience all three simultaneously, a combination sometimes referred to as pancytopenia.
Common Causes
Chemotherapy is the most common trigger. Cancer drugs are designed to kill rapidly dividing cells, but bone marrow stem cells also divide rapidly, making them collateral damage. After a round of chemotherapy, blood counts typically fall over the following days, reaching their lowest point (called the nadir) at a median of about 19 days, though the range can span anywhere from 6 to 50 days depending on the drug regimen.
Blood cancers themselves can cause myelosuppression even before treatment begins. In leukemia, lymphoma, and myeloma, abnormal cells crowd the bone marrow and physically displace healthy stem cells, reducing normal blood cell output.
A range of non-chemotherapy medications can also suppress blood counts. Antithyroid drugs used for Graves’ disease (such as propylthiouracil and carbimazole) carry a roughly 0.2% to 0.5% risk of dropping white blood cells dangerously low. The antipsychotic clozapine, used for treatment-resistant schizophrenia, causes the same problem in about 1% of patients. Certain antibiotics, including amoxicillin and cotrimoxazole, and the antiplatelet drug ticlopidine are also frequently linked to drug-induced neutropenia.
Viruses are another culprit. Some infections trigger the immune system to consume white blood cells faster than the marrow can replace them. Other viruses appear to directly infect the blood-forming cells themselves, lowering output at the source.
What Myelosuppression Feels Like
The symptoms depend on which blood cell type is most affected, and they often overlap.
- Low red blood cells (anemia): fatigue that rest doesn’t fix, shortness of breath during normal activities, dizziness, rapid heartbeat, pale skin, and feeling cold.
- Low white blood cells (neutropenia): frequent or severe infections, fevers, mouth sores, and slow wound healing. Because your immune defense is weakened, even a minor cut or cold can escalate quickly.
- Low platelets (thrombocytopenia): easy bruising, tiny red or purple dots on the skin (petechiae), nosebleeds, bleeding gums, and prolonged bleeding from small cuts.
These symptoms tend to worsen as blood counts fall further. Many people report that myelosuppression significantly affects their quality of life, causing exhaustion and anxiety about infection during what is already a difficult treatment period.
Severity Grading
Doctors grade myelosuppression by measuring specific blood counts. Understanding these thresholds can help you make sense of lab results.
Neutropenia (White Blood Cells)
The key number is the absolute neutrophil count, or ANC. Mild neutropenia is an ANC between 1,000 and 1,500. Moderate falls between 500 and 1,000. Severe neutropenia is below 500, and profound neutropenia, below 100, carries the highest infection risk. A fever above 100.4°F lasting at least an hour with an ANC below 1,500 qualifies as febrile neutropenia, a medical emergency that typically requires immediate treatment with antibiotics.
Anemia (Red Blood Cells)
Hemoglobin levels determine severity. Mild anemia is a hemoglobin between 10 and the lower limit of normal (roughly 12 for women, 14 for men). Moderate is 8 to 10 g/dL. Severe falls between 6.5 and 7.9, and anything below 6.5 is considered life-threatening.
Thrombocytopenia (Platelets)
Platelet counts below 10,000 raise serious concern for spontaneous bleeding, meaning bleeding that starts without any injury. At that level, people often notice petechiae and bruising from minimal contact.
How Myelosuppression Is Treated
Treatment focuses on supporting the bone marrow and managing the consequences of low counts until production recovers.
For neutropenia, growth factor injections can stimulate the marrow to produce white blood cells faster. These are typically given one to three days after chemotherapy and continued daily until white blood cell counts recover. A longer-acting version requires only a single injection the day after treatment. Guidelines recommend these injections when the risk of developing febrile neutropenia exceeds 20%, and they’re required for dose-dense chemotherapy regimens with shortened intervals between cycles.
For anemia, red blood cell transfusions are the fastest fix. An alternative for patients whose hemoglobin drops below 10 g/dL is an injection that stimulates the body to make its own red blood cells, similar to a synthetic version of a hormone your kidneys naturally produce. These injections reduce the need for transfusions, though they carry their own risks and are reserved for people actively receiving chemotherapy who are symptomatic.
For thrombocytopenia, platelet transfusions are used when counts drop dangerously low or active bleeding occurs. There is less pharmacologic support available for low platelets compared to the other cell lines, so dose adjustments to the offending medication are often the primary strategy.
A newer approach involves giving a protective drug before chemotherapy that temporarily pauses bone marrow stem cells from dividing. Because the stem cells are dormant during the window when chemotherapy is active, they’re shielded from damage. Once the protective drug wears off, the stem cells resume dividing and producing blood cells normally.
Living With Low Blood Counts
During periods of myelosuppression, the practical risks shift in ways that require changes to daily routines. With low white blood cells, avoiding infection becomes a priority. That means frequent handwashing, steering clear of crowds and sick contacts, and paying close attention to food safety (avoiding raw meats, unwashed produce, and buffet-style meals where food sits at room temperature).
With low platelets, the goal is preventing bleeding. Use a soft-bristle toothbrush, avoid flossing aggressively, skip contact sports, and be cautious with sharp objects. Even blowing your nose too hard can trigger a nosebleed that’s difficult to stop.
With anemia, energy management matters. Prioritize rest, break tasks into smaller chunks, and stay hydrated. Shortness of breath during simple activities like climbing stairs or walking across a room is a sign your red blood cells have dropped significantly.
Blood counts are monitored frequently during treatment, often multiple times per week near the expected nadir. These regular checks allow your care team to intervene before counts reach dangerous levels, whether through growth factors, transfusions, or adjusting treatment timing and doses.